Copper Ions Are Novel Therapeutic Agents for Uterine Leiomyosarcoma

American Journal of Obstetrics and Gynecology - United States
doi 10.1016/j.ajog.2019.07.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cancer‑testis Antigens Are Predominantly Expressed in Uterine Leiomyosarcoma Compared With Non‑uterine Leiomyosarcoma

Oncology Letters
Cancer ResearchOncology
2017English

Adjuvant Therapy for Early Uterine High-Grade Leiomyosarcoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

Novel Therapeutic Agents for Relapsed Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Simvastatin and Uterine Fibroids: Opportunity for a Novel Therapeutic Option

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Epithelioid Leiomyosarcoma: A Rare Uterine Cancer

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2018English

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease

Frontiers in Neurology
Neurology
2017English

Uterine Leiomyosarcoma Presenting With a Fever of Unknown Origin

Internal Medicine
Internal MedicineMedicine
2015English

Uterine Leiomyosarcoma With Breast Metastasis: A Case Report

Journal of Cancer Science and Clinical Therapeutics
2018English

Serum microRNA Profile Enables Preoperative Diagnosis of Uterine Leiomyosarcoma

Cancer Science
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy